# Paclitaxel

NDC: 46708-621
Generic name: Paclitaxel
Labeler / Manufacturer: Alembic Pharmaceuticals Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20221020

FDA application: ANDA216874

## Active ingredients

- PACLITAXEL: 6 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"46708-621"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=46708-621
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6d04b514-c85c-4db1-919e-21dd98172791